These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 3286265)

  • 1. Delayed repolarization as antiarrhythmic action.
    Olsson SB; Edvardsson N
    Eur Heart J; 1988 Feb; 9 Suppl B():37-43. PubMed ID: 3286265
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation.
    Olsson SB; Edvardsson N
    Am Heart J; 1981 Nov; 102(5):864-71. PubMed ID: 7304394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
    Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
    Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
    [No Abstract]   [Full Text] [Related]  

  • 5. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.
    Coronel R; Janse MJ; Opthof T; Wilde AA; Taggart P
    Heart Rhythm; 2012 Jun; 9(6):977-82. PubMed ID: 22293142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmic drugs and heart conduction].
    Furlanello F
    G Clin Med; 1973 Jul; 54(7):382-406. PubMed ID: 4779853
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of cardiac arrhythmias.
    Singer DH; Ten Eick RE
    Prog Cardiovasc Dis; 1969 May; 11(6):488-514. PubMed ID: 4892942
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of cardiac arrhythmias.
    Waldo AL; Wit AL
    Lancet; 1993 May; 341(8854):1189-93. PubMed ID: 8098085
    [No Abstract]   [Full Text] [Related]  

  • 9. The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias.
    Kowey PR; Robinson VM
    Circulation; 2020 May; 141(19):1507-1509. PubMed ID: 32392105
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
    Skibsbye L; Ravens U
    Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Choice of cardiac antiarrhythmia agents].
    Kappenberger L; Biollaz J
    Ther Umsch; 1987 Aug; 44(8):591-5. PubMed ID: 3672412
    [No Abstract]   [Full Text] [Related]  

  • 13. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic therapy of arrhythmias.
    Naccarelli GV; Rinkenberger RL; Dougherty AH; Berns E; Crandell JR
    Hosp Pract (Off Ed); 1988 Oct; 23(10):183-7, 190-2, 194-5 passim. PubMed ID: 3139691
    [No Abstract]   [Full Text] [Related]  

  • 15. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration.
    Pandit SV; Noujaim SF; Jalife J
    Heart Rhythm; 2012 May; 9(5):e13-4; author reply e14. PubMed ID: 22426151
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ethacizine on the heart conduction system and the indicators of central hemodynamics].
    Gorshkov VA; Nesvetov VN; Kesarev GV; Sherashov VS; Mamaev VI
    Sov Med; 1991; (8):9-11. PubMed ID: 1763379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drugs.
    Rosen MR; Gelband H
    Am Heart J; 1971 Mar; 81(3):428-36. PubMed ID: 4926360
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmias and antiarrhythmic drugs.
    Urthaler F
    Ala J Med Sci; 1984 Jul; 21(3):275-83. PubMed ID: 6476289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.